Form 4: Cingulate Inc. Director Peter J. Werth Granted 15,000 Stock Options

Cingulate Inc. Director Peter J. Werth was granted 15,000 stock options with an exercise price of $4.14, aligning his interests with shareholder value.

Summary

• Peter J. Werth, a Director of Cingulate Inc. (CING), was granted 15,000 stock options.
• The options have an exercise price of $4.14 per share.
• The grant date for these options was June 20, 2025.
• Each option represents the right to buy one share of Cingulate Inc. Common Stock.
• The options will vest on the earlier of June 20, 2026 (one-year anniversary of the grant date) or the date of Cingulate Inc.'s 2026 annual meeting of stockholders.
• The options expire on June 20, 2035.
• Following this transaction, Mr. Werth beneficially owns 15,000 derivative securities (stock options) directly.

Sentiment

Score: 6

Explanation: Slightly positive. The grant of stock options aligns the director's interests with shareholder value, which is generally viewed favorably as an incentive for long-term performance. It's a routine compensation event.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, as the options gain value only if the company's stock price increases above the exercise price.
• Equity compensation is a common incentive for retaining and motivating key personnel.

Negatives

• Potential future dilution if the options are exercised, although this is a standard aspect of equity compensation plans.

Risks

• No specific risks are detailed in this Form 4 filing, as it primarily reports an insider transaction.

Future Outlook

The grant of stock options indicates a long-term incentive for the director, suggesting an expectation of future stock price appreciation and continued engagement with the company's performance.

Industry Context

Granting stock options to directors and executives is a standard practice across various industries, particularly in publicly traded companies, to align their financial interests with long-term shareholder value creation. This is a common form of non-cash compensation.

Comparison to Industry Standards

• Equity compensation, such as stock options, is a widely accepted and common practice for compensating directors and executives in publicly traded companies across all sectors.
• The specific size of the grant (15,000 options) and the exercise price ($4.14) would typically be evaluated against Cingulate Inc.'s compensation policies, peer group compensation, and the company's market capitalization and stage of development. Without specific comparable company data, a general statement is appropriate.

Corporate Governance

Related Party Transactions

• The grant of stock options to a director is a related party transaction, but it is a standard and disclosed form of compensation. No unusual related party dealings are indicated beyond this.

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also benefit from aligned interests of the director with long-term stock performance.
• Management/Directors: Peter J. Werth receives equity compensation, incentivizing his performance.

Next Steps

• Vesting of the granted stock options on or after June 20, 2026, or the 2026 annual meeting.
• Potential exercise of the options by Peter J. Werth before the expiration date of June 20, 2035, assuming the stock price is above the exercise price.

Key Dates

Keywords

Cingulate Inc., CING, Peter J. Werth, Form 4, SEC filing, Stock Option, Equity Compensation, Insider Transaction, Director, Corporate Governance